Mid-Afternoon Market Update: Dow Falls 100 Points; Sarepta Therapeutics Shares Drop Following Release of FDA Briefing Documents on Eteplirsen

By: via Benzinga
Toward the end of trading Thursday, the Dow traded down 0.57 percent to 17,993.92 while the NASDAQ declined 0.10 percent to 4,943.05. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.